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The in vitro activities of 6 antimicrobial agents against clinical isolates of Streptococcus 
pneumoniae (pneumococci) were investigated and the erythromycin minimum inhibitory 
concentrations (MICs) were correlated with the two major macrolide resistance determinants, 
mef(A) and erm(B). MICs of commonly used antibiotics as well as the presence of macrolide 
resistance determinant genes in all isolates were tested. Seventy one pneumococcal isolates 
collected at Institute for Medical Research (IMR) were included in this study. Phenotypic 
characterization, MIC determination using E-test strips and polymerase chain reactions for 
antibiotic resistance determination were included. Among the isolates, 25 (35.2%) isolates 
were erythromycin susceptible, 3 (4.2%) were intermediate and 42 (60.6%) were resistant. 
Fifty three isolates (74.7%) were found with mef(A) alone, 15 (21.1%) isolates with erm(B) + 
mef(A) combination and 3 (4.2%) isolates with none of the two genes. The in vitro activity of 
penicillin, amoxicillin clavulanic acid, ceftriaxone and cefotaxime is superior to 
trimethoprim-sulfamethoxazole and erythromycin. In conclusion, pneumococcal isolates in 
this study were highly susceptible to penicillin with very low MICs. However, a very high 
prevalence rate of erythromycin resistance was observed. Erythromycin resistant S. 
pneumoniae isolates with both mef(A) and erm(B) showed very high MICs ≥256 μg/mL. 
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